McDonald's Tests New Menu Concepts for GLP-1 Users

The company is exploring protein-rich menu options for customers on GLP-1 medications, though no official launch is planned.

Updated on Oct. 31, 2026 in Diabetes

Bold vector editorial illustration of a grilled chicken breast and broccoli, representing evolving menu options for health-conscious consumers. — McDonald's is developing protein-rich menu concepts for customers using GLP-1 medications, though the restaurant chain has not set a timeline for a rollout. AI Illustration. Upload story photo >

Live Poll

Would you choose to buy menu items specifically marketed toward GLP-1 medication users?

McDonald's is currently in the early stages of developing new menu concepts aimed at customers who are taking GLP-1 medications. While the company is exploring protein-focused options, no official dedicated menu or rollout timeline has been announced.

Why it matters

As the prevalence of GLP-1 medication usage grows, the company is adjusting its culinary strategy to align with changing customer preferences for protein-rich options. This development reflects how major restaurant chains are responding to the evolving dietary habits of health-conscious consumers.

The company is engaged in preliminary culinary research to evaluate potential menu items against existing brand strategies. Details regarding the final product composition and restaurant availability remain unknown, as the initiative is still in its early development phase.

The players

McDonald's

A global quick-service restaurant chain currently adapting its menu strategy to address shifting consumer dietary habits and preferences.

Wayne Kuhl

An executive who provided updates on the company's early-stage culinary development processes during a recent public event.

The details

Culinary teams are evaluating new menu ideas by focusing on product appearance, texture, and operational ease within existing restaurant kitchens. Development efforts are prioritizing protein-forward items, specifically exploring concepts involving hand-breaded and grilled chicken. This process assesses how potential new offerings fit alongside established items like the egg-based Egg McMuffin or all-white meat Chicken McNuggets.

October 29, 2026: Executive leadership discussed the current status of menu development initiatives.

Health Landscape

The move reflects an industry-wide pivot as major retailers react to shifting nutritional priorities among patients managing their weight. This trend follows the broader adoption of GLP-1 medications and the subsequent change in consumer demand for high-protein food options.

If you are using GLP-1 medications, prioritize protein-rich whole foods as recommended by your clinical team. Changes in commercial menu availability are in the planning stage, so rely on your personalized nutritional plan rather than expecting new fast-food options in the near term.

The takeaway

While restaurant chains are exploring menu adjustments for users of GLP-1 medications, these items remain in early development and are not currently available. Focus on maintaining a protein-balanced diet and continue discussing your long-term nutritional goals with your physician.